Results 81 to 90 of about 1,696 (185)

Circulating histones as clinical biomarkers in critically ill conditions

FEBS Letters, Volume 599, Issue 22, Page 3174-3195, November 2025.
Circulating histones are emerging as promising biomarkers in critical illness due to their diagnostic, prognostic, and therapeutic potential. Detection methods such as ELISA and mass spectrometry provide reliable approaches for quantifying histone levels in plasma samples.
José Luis García‐Gimenez, Juan Carlos Ruiz‐Rodríguez, Ricard Ferrer, Raquel Durá, Antonio Artigas, Iván Bajaña, David Bolado López de Andujar, Irene Cánovas‐Cervera, Adrián Ceccato, Luis Chiscano‐Camón, Elena Climent‐Martinez, Georgia García Fernández, Gemma Goma, Verónica Monforte, Beatriz Quevedo‐Sánchez, Adolf Ruiz‐Sanmartín, Antonio Sierra‐Rivera, Nieves Carbonell Monleón   +17 more
wiley   +1 more source

Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome

Case Reports in Critical Care, 2017
Background. Toxic shock syndrome is a potentially fatal toxin-mediated disease. The role of toxins in this clinical entity made us hypothesize that extracorporeal blood purification with CytoSorb® could play a beneficial role in the clinical management ...
Andrea Berkes, Edit Szikszay, János Kappelmayer, Adrienne Kerényi, Tamás Szabó, László Ujhelyi, Krisztina Bari, György Balla, József Balla   +8 more
doaj   +1 more source

Experience with hemoadsorption (CytoSorb^®) in the management of septic shock patients

World Journal of Critical Care Medicine, 2020
Cytokines and inflammatory mediators are the hallmarks of sepsis. Extracorporeal cytokine hemoadsorption devices are the newer clinical support system to overcome the cytokine storm during sepsis.To retrospectively evaluate the clinical outcomes of patients admitted in intensive care unit with septic shock with different etiologies.The laboratory ...
Mehta, Yatin, Mehta, Chitra, Kumar, Ashish, George, Joby Varghese, Gupta, Aditi, Nanda, Saurabh, Kochhar, Gourav, Raizada, Arun   +7 more
openaire   +2 more sources

Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T‐Cell Immunotherapy for B‐Cell Malignancies: A Case Series

Hematological Oncology, Volume 44, Issue 4, July 2026.
Gianluca Cavallaro, Silvia Ferrari, Anna Pollastri, Elena Di Credico, Cristian Meli, Monica Rondi, Alessandro Putelli, Federico Lussana, Anna Grassi, Alessandro Rambaldi, Tino Martino Valetti, Ivano Riva, Giuseppe Gritti   +12 more
wiley   +1 more source

Kidney injury in patients with heart failure‐related cardiogenic shock: Results from an international, multicentre cohort study

European Journal of Heart Failure, Volume 27, Issue 11, Page 2397-2409, November 2025.
Kidney injury in heart failure‐related cardiogenic shock. AKI, acute kidney injury; CI, confidence interval; eCPR, extracorporeal cardiopulmonary resuscitation; eGFR, estimated glomerular filtration rate; HR, hazard ratio; OR, odds ratio; VA‐ECMO, veno‐arterial extracorporeal membrane oxygenation.
Jonas Sundermeyer, Caroline Kellner, Benedikt N. Beer, Lisa Besch, Angela Dettling, Letizia Fausta Bertoldi, Stefan Blankenberg, Jeroen Dauw, Dennis Eckner, Ingo Eitel, Tobias Graf, Patrick Horn, Joanna Jozwiak‐Nozdrzykowska, Paulus Kirchhof, Stefan Kluge, Axel Linke, Ulf Landmesser, Enzo Lüsebrink, Nicolas Majunke, Norman Mangner, Sven Möbius Winkler, Peter Nordbeck, Martin Orban, Federico Pappalardo, Matthias Pauschinger, Michal Pazdernik, Alastair Proudfoot, Matthew Kelham, Tienush Rassaf, Hermann Reichenspurner, Clemens Scherer, P. Christian Schulze, Robert H.G. Schwinger, Carsten Skurk, Marek Sramko, Guido Tavazzi, Holger Thiele, Luca Villanova, Nuccia Morici, Ephraim B. Winzer, Dirk Westermann, Benedikt Schrage   +41 more
wiley   +1 more source

Improved survival beyond 28 days up to 1 year after cytosorb treatment for refractory septic shock: A propensity-weighted retrospective survival analysis [PDF]

, 2020
Background and Aims: It is currently unknown whether CytoSorb treatment for septic shock improves long-term survival beyond 28 days from intensive care unit (ICU) admission and which factors determine outcome.
Brouwer, W.P. (Willem), Duran, Servet, Ince, C. (Can), Brouwer, Willem P.; id_orcid, Brouwer, Willem P., Ince, Can, Duran, S. (Servet)   +6 more
core   +1 more source

CytoSorb in the management of severe septic shock after coronary artery bypass graft surgery

Heart India, 2020
Achieving sufficient adsorption of increased immune mediators with the help of hemadsorption has been a breakthrough discovery in the field of cardiac sciences.
Amit Prakash, Vishal Garg, Dinesh Kumar Mittal, Anurag Bhushan Upadhyay   +3 more
doaj   +1 more source

Effects of empagliflozin on uric acid levels during acute heart failure recompensation: A sub‐analysis of the EMPAG‐HF trial (Effects of Empagliflozin on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure)

European Journal of Heart Failure, Volume 27, Issue 8, Page 1472-1478, August 2025.
Effects of empagliflozin on uric acid levels during acute heart failure recompensation. Abstract Background Sodium–glucose cotransporter 2 inhibitors improve prognosis in chronic heart failure as part of currently recommended therapeutic strategies.
Jurgen Bogoviku, Tien Dung Nguyen, Julian Georg Westphal, Franz Haertel, Pawel Aftanski, Sven Möbius‐Winkler, Martin Busch, P. Christian Schulze   +7 more
wiley   +1 more source

Supplementary Material for: Extracorporeal blood purification with CytoSorb in 359 critically ill patients

, 2023
Introduction. Critically ill patients with inflammatory dysregulation and organ disfunction may benefit from blood purification, although the use of this technique has not been described in large case series.
Belletti A. (16875384), Calabrò M.G. (16875387), Bonizzoni M.A. (16875381), Ortalda A. (16875396), Scandroglio A.M. (16875399), Pieri M. (16875378), Fominskiy E. (16875390), Nardelli P. (16875393)   +7 more
core   +1 more source

Current and novel biomarkers in cardiogenic shock

European Journal of Heart Failure, Volume 27, Issue 6, Page 1106-1125, June 2025.
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko, Florian A. Wenzl, Christophe Vandenbriele, Vasileios Panoulas, Thomas F. Lüscher, Diana A. Gorog   +5 more
wiley   +1 more source